Virtu Financial’s Twist Bioscience TWST Stock Holding History

Virtu Financial’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,273	Closed	-$526K	–	2117
2023 Q4	$526K	Buy	+14,273	New	+$330K	0.04%	393
2023 Q1	–	Sell	-16,292	Closed	-$388K	–	2114
2022 Q4	$388K	Buy	16,292 +9,577	+143%	+$278K	0.05%	370
2022 Q3	$237K	Buy	+6,715	New	+$285K	0.02%	774
2022 Q1	–	Sell	-5,628	Closed	-$436K	–	2049
2021 Q4	$436K	Buy	+5,628	New	+$578K	0.04%	432
2021 Q2	–	Sell	-21,019	Closed	-$2.6M	–	2085
2021 Q1	$2.6M	Buy	21,019 +15,070	+253%	+$2.29M	0.18%	67
2020 Q4	$841K	Buy	5,949 +262	+5%	+$29.1K	0.09%	278
2020 Q3	$432K	Buy	+5,687	New	+$354K	0.07%	328
2019 Q4	$222K	Buy	+10,575	New	+$247K	0.02%	866

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Virtu Financial's TWST Position: Q1 2024 in Review

Virtu Financial sold out of Twist Bioscience (TWST) in Q1 2024, closing a stake of 14,273 shares — an estimated $526K sold.

Virtu Financial first reported a position in TWST in Q4 2019 and held it in 8 quarters. The position peaked at $2.6M in Q1 2021. 237 funds tracked by Wall St. Rank hold TWST as of Q1 2024.

Virtu Financial reported no remaining Twist Bioscience position as of Q1 2024 after selling out during the quarter.
Virtu Financial sold 14,273 Twist Bioscience shares in Q1 2024, an estimated $526K.
Virtu Financial first reported a position in Twist Bioscience in Q4 2019 and held it in 8 quarters.
Virtu Financial's Twist Bioscience position peaked at $2.6M in Q1 2021.
237 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.